History of Present Illness: This is a [**Age over 90 **] year old male with PMH of Alzheimer's disease, bilateral inguinal hernias, BPH, constipation, bilateral heel ulcers, s/p 3 documented falls since [**2195-2-13**] presenting with increasing abdominal pain and decreased PO intake over the past week.
He stopped taking solid foods PO 5 days prior to presentation and stopped taking fluids 3 days prior to presentation.
He saw his PCP yesterday and was started on enemas and magnesium citrate PO as well as cipro/flagyl to empirically cover for a GI source of infection.
The patient has been in severe pain from his bilateral heel ulcers and is on an aggressive opiate pain regimen with a minimal bowel regimen.
A Foley was placed and drained 1.5L of urine.
Patient was given ciprofloxacin and flagyl, 2L of NS boluses, and morphine 4mg IV.
Family History: Non-contributory  Physical Exam: Admission Exam: Vitals: T: 98 BP: 139/46 P: 110s-130s R: 18 O2: 94% RA General: Elderly male, somnolent, but will respond to his name HEENT: Sclera anicteric, dry MM, oropharynx clear, hematoma noted on the left side of his forehead Neck: supple, JVP flat Lungs: Clear to auscultation anteriorly CV: Irregularly irregular, tachycardic Abdomen: firm, diffusely tender, distended, hypoactive bowel sounds, no rebound tenderness or guarding GU: Foley in place Ext: warm, well perfused; Dopplerable pulses; no clubbing, cyanosis or edema; bilateral necrotic heel ulcers noted   Pertinent Results: STUDIES: CXR ([**2195-6-20**]) - IMPRESSION: 1.
Porceline gallbladder with cholelithiasis, generally considered to represent a substantial risk of developing gallbladder cancer.
Mild bilateral hydronephrosis with hydroureter on the left without definite source.
LABS: [**2195-6-20**] 12:30PM BLOOD WBC-26.4*# RBC-4.33* Hgb-11.6* Hct-35.9* MCV-83 MCH-26.8* MCHC-32.3 RDW-15.4 Plt Ct-236 [**2195-6-20**] 07:05PM BLOOD WBC-18.4* RBC-3.57* Hgb-9.6* Hct-30.2* MCV-85 MCH-26.8* MCHC-31.7 RDW-15.1 Plt Ct-207 [**2195-6-21**] 04:48AM BLOOD WBC-15.3* RBC-3.65* Hgb-10.0* Hct-31.1* MCV-85 MCH-27.4 MCHC-32.2 RDW-14.9 Plt Ct-202 [**2195-6-22**] 06:15AM BLOOD WBC-11.8* RBC-3.62* Hgb-9.8* Hct-30.8* MCV-85 MCH-27.1 MCHC-31.9 RDW-14.5 Plt Ct-188 [**2195-6-23**] 07:16AM BLOOD WBC-10.6 RBC-3.71* Hgb-10.2* Hct-31.7* MCV-86 MCH-27.6 MCHC-32.2 RDW-14.8 Plt Ct-197 [**2195-6-24**] 03:15PM BLOOD WBC-12.0* RBC-4.16* Hgb-10.7* Hct-34.6* MCV-83 MCH-25.8* MCHC-31.0 RDW-14.2 Plt Ct-246 [**2195-6-25**] 07:25AM BLOOD WBC-11.0 RBC-4.30* Hgb-11.1* Hct-35.5* MCV-83 MCH-25.7* MCHC-31.2 RDW-14.5 Plt Ct-236 [**2195-6-20**] 12:30PM BLOOD Neuts-92* Bands-0 Lymphs-2* Monos-6 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2195-6-20**] 07:05PM BLOOD Neuts-92.3* Lymphs-2.9* Monos-4.4 Eos-0.4 Baso-0 [**2195-6-20**] 12:30PM BLOOD PT-13.2 PTT-24.8 INR(PT)-1.1 [**2195-6-21**] 04:48AM BLOOD PT-13.8* PTT-26.6 INR(PT)-1.2* [**2195-6-22**] 06:15AM BLOOD PT-15.2* PTT-29.4 INR(PT)-1.3* [**2195-6-23**] 07:16AM BLOOD ESR-17* [**2195-6-20**] 12:30PM BLOOD Glucose-233* UreaN-50* Creat-1.9*# Na-144 K-3.9 Cl-103 HCO3-31 AnGap-14 [**2195-6-21**] 04:48AM BLOOD Glucose-197* UreaN-37* Creat-0.9 Na-149* K-3.6 Cl-111* HCO3-33* AnGap-9 [**2195-6-22**] 06:15AM BLOOD Glucose-183* UreaN-24* Creat-0.6 Na-147* K-3.1* Cl-109* HCO3-32 AnGap-9 [**2195-6-23**] 07:16AM BLOOD Glucose-130* UreaN-14 Creat-0.5 Na-140 K-3.5 Cl-105 HCO3-29 AnGap-10 [**2195-6-24**] 03:15PM BLOOD Glucose-135* UreaN-10 Creat-0.5 Na-136 K-3.2* Cl-101 HCO3-24 AnGap-14 [**2195-6-25**] 07:25AM BLOOD Glucose-128* UreaN-8 Creat-0.5 Na-137 K-3.0* Cl-100 HCO3-28 AnGap-12 [**2195-6-21**] 04:48AM BLOOD CK(CPK)-23* [**2195-6-25**] 07:25AM BLOOD ALT-19 AST-28 AlkPhos-100 TotBili-0.4 [**2195-6-20**] 12:30PM BLOOD ALT-18 AST-15 AlkPhos-129 TotBili-0.5 [**2195-6-20**] 12:30PM BLOOD Lipase-8 [**2195-6-20**] 07:05PM BLOOD CK-MB-2 cTropnT-0.03* [**2195-6-21**] 04:48AM BLOOD CK-MB-3 cTropnT-0.03* [**2195-6-20**] 07:05PM BLOOD Calcium-7.8* Phos-3.5 Mg-2.5 [**2195-6-22**] 06:00PM BLOOD Mg-1.9 [**2195-6-24**] 03:15PM BLOOD Calcium-8.0* Phos-2.6* Mg-1.8 [**2195-6-25**] 07:25AM BLOOD Calcium-8.3* Phos-2.6* Mg-1.9 [**2195-6-21**] 04:48AM BLOOD %HbA1c-6.8* eAG-148* [**2195-6-23**] 07:16AM BLOOD CRP-85.9* [**2195-6-21**] 04:48AM BLOOD TSH-1.2 [**2195-6-20**] 07:05PM BLOOD Osmolal-309 [**2195-6-20**] 12:40PM BLOOD Lactate-1.9 [**2195-6-20**] 12:55PM URINE Color-Yellow Appear-Hazy Sp [**Last Name (un) **]-1.022 [**2195-6-21**] 04:48AM URINE Color-Yellow Appear-Hazy Sp [**Last Name (un) **]-1.018 [**2195-6-24**] 04:43PM URINE Color-Yellow Appear-Clear Sp [**Last Name (un) **]-1.016 [**2195-6-20**] 12:55PM URINE Blood-NEG Nitrite-NEG Protein-25 Glucose-NEG Ketone-NEG Bilirub-SM Urobiln-4* pH-5.0 Leuks-SM [**2195-6-21**] 04:48AM URINE Blood-MOD Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-5.5 Leuks-LG [**2195-6-24**] 04:43PM URINE Blood-TR Nitrite-NEG Protein-30 Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-2* pH-6.5 Leuks-TR [**2195-6-20**] 12:55PM URINE RBC-0-2 WBC-[**7-23**]* Bacteri-MANY Yeast-NONE Epi-0 [**2195-6-21**] 04:48AM URINE RBC-158* WBC-65* Bacteri-NONE Yeast-NONE Epi-0 [**2195-6-24**] 04:43PM URINE RBC-29* WBC-5 Bacteri-FEW Yeast-NONE Epi-<1 [**2195-6-21**] 04:48AM URINE CastHy-8* [**2195-6-20**] 12:55PM URINE Mucous-MANY [**2195-6-21**] 04:48AM URINE Mucous-MOD [**2195-6-24**] 04:43PM URINE Mucous-FEW [**2195-6-20**] 12:55PM URINE CaOxalX-MOD .
On arrival to the ICU, the patient was noted to aspirate oral medications and was therefore made NPO.
He was treated with aggressive bowel regimen, including senna, colace, bisacodyl,  lactulose enemas.
Given loops of bowel in scrotum, and concern for incarceration, surgical service was consulted, who recommended conservative management.
Upon arrival to the medical floor, he was continued on aggressive bowel regimen including daily tap water and/or mineral oil enemas, disimpaction x1.
Surgical service signed off, and pt was discharged back to rehab with instructions to continue aggressive daily bowel regimen with goal of 2 soft BMs per day.
Upon arrival to the ED, a Foley was placed and drained 1.5 Liters of urine.
He was discharged to Rehab with foley catheter in place.
After discussion with podiatry, heel infection was felt less likely, and vancomycin was discontinued.
His leukocytosis resolved with treatment of UTI and constipation.
IV vancomycin was started empirically on admission, and podiatry service was consulted, who felt there was no evidence of infection.
Podiatry made wound care recommendations as below, including treatment with enzymatic debridement: -offloading with multipodus boots bilaterally -daily wet to dry dressing changes -santyl enzymatic dressing changes on the right heel.
He was treated with iv metoprolol prn in ICU, however did not require additional rate control medications upon arrival to the floor.
His CHADs score is [**2-14**] (not clearly diabetic), therefore he should be covered with aspirin daily.
Should he have elevated heart rates, he can be started on low dose metoprolol, which can be uptitrated as needed.
# BPH - Home doxazosin was held on admission given hypotension, and resumed prior to discharge.
# hyperglycemia - no h/o diabetes, mildly elevated FSBS in ICU, A1c 6.8.  not requiring insulin on floor.
# COMM - Patient; [**Name (NI) 32851**] [**Name (NI) **] (son/HCP/retired ENT physician) [**Telephone/Fax (1) 77596**] (home) + [**Telephone/Fax (1) 77597**] (cell); [**Name (NI) 122**] [**Name (NI) 77598**] (son) [**Telephone/Fax (1) 77599**]; Newbridge on the [**Doctor Last Name **] nursing facility [**Telephone/Fax (1) 77600**]  Medications on Admission: (Per Nursing Home Records) - Ciprofloxacin 500mg PO BID (started [**6-19**]) - Flagyl 500mg PO TID (started [**6-19**]) - Oxycodone IR 2.5mg-10mg PO q4 PRN pain - Oxycodone IR 2.5mg daily at 7AM - Morphine 4mg PO hourly PRN - Lorazepam 0.5mg PO q4 PRN - Artificial tears 1gtt OU [**Hospital1 **] - Milk of Magnesia 30cc PO daily PRN - Bisacodyl 10mg PR PRN - Doxazosin 2mg PO HS - Simethicone 40mg TID PRN - EMLA cream PRN to heels prior to debridement - Hyoscyamine sulfate 0.25mg q6 PRN - Prochlorperazine 25mg PR q12 PRN - Senna 17.2mg PO HS - Lactulose 10gm daily   Discharge Medications: 1.
Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 2 days.
Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for pain: please try tylenol first, use oxycodone only if pain is severe.
Polyvinyl Alcohol-Povidone 1.4-0.6 % Dropperette Sig: [**2-14**] Drops Ophthalmic [**Hospital1 **] (2 times a day).
Zinc Sulfate 220 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1)  PO BID (2 times a day) as needed for constipation: titrate to 2 soft bowel movements daily.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal [**Hospital1 **] (2 times a day) as needed for constipation: titrate to 2 soft bowel movements daily.
Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO QID (4 times a day): titrate to 2 soft bowel movements daily.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day): titrate to 2 soft bowel movements daily.
Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours).
Doxazosin 1 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime).
Aspirin 325 mg Tablet Sig: One (1) Tablet PO once a day.
you were seen by the surgical service given your inguinal hernias, who felt that no surgical intervention was required.
you were treated with aggressive bowel regimen, enemas, and disimpaction, and your constipation resolved.
you were treated with an antibiotic for your UTI.
the following changes were made to your medication regimen: 1. you were started on an aggressive bowel regimen including daily senna, colace, bisacodyl, lactulose, miralax, and tap water/mineral oil enemas daily as needed to facilitate 2 soft bowel movements per day.
2. you were started/continued on ciprofloxacin to complete a 5 day course for your UTI.
Followup Instructions: upon arriving home, please contact your primary care physician, [**Name10 (NameIs) **] arrange to be seen within 1-2 weeks of your discharge for routine follow-up.
